Diagnostics

We invest in better, more affordable diagnostics because they are foundational to strong health systems. Our work spans innovation, manufacturing, and implementation, grounded in the belief that diagnostics are not just tools for detection but also catalysts for more effective and equitable health care.

Our current strategy focuses on end-to-end impact: identifying the highest priority use cases across diseases such as TB, malaria, HIV, and sexually transmitted infections; building a pipeline of diagnostic platforms that can be developed and manufactured cost-effectively; and ensuring that these tools are used consistently and effectively at the point of care. In doing so, we seek out local partnerships, especially with manufacturers in India and China, to shape resilient regional ecosystems that can deliver high-quality diagnostics on a large scale. To ensure sustainable use, we ground our innovation efforts in real-world implementation settings. Through this work, we aim to demonstrate how timely access to low-cost diagnostics can improve health outcomes and make the most of health care spending.

Ultimately, we believe that better access to diagnostics leads to better decisions, more efficient programs, and stronger health systems.